Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20035187 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel

Indicates status has not been verified in more than two years